Drug Discovery Webinars

1. Quality Roundtable: Optimizing Biologics Manufacturing Processes With Raw Materials 1/24/2024

   Improve your commercial manufacturing process with advice from regulatory and raw materials experts on the development journey from pre-clinical to licensure.

2. Leveraging Stable Pool Material To Expedite The Path To IND 1/10/2024

   Review the efficacy of fast stable pools in generating purified product at an early stage and learn how to accelerate the journey toward first-in-human trials and proof-of-concept studies.

3. Harnessing New Tech To Create Next-Generation GS-CHO Expression Solutions 12/6/2023

   What makes a next-generation CHO bioproduction process? Take a journey through areas of innovation for creating expression systems of the future, with a focus on DNA and cell expression technologies.

4. Bio Career Moves With Codagenix's Johanna Kaufmann, Ph.D. 10/11/2023

   On this week's episode of the Business of Biotech, Dr. Johanna Kaufmann gives us an intimate retrospective on her career to date, sharing stories about her rapid ascension from Scientist 1 to executive leadership. We dig into her wild ride through M&A, her time at GSK, and the professional and personal development regimens she subscribes to.

5. Don't Skip Preformulation: Your Blueprint For Drug Development Success 9/22/2023

   Investing in the right preformulation studies and gathering evidence to inform decisions is critical to identify product dead-ends and failure modes without the pain of hindsight.

6. Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD 8/16/2023

   Since we last spoke in the Spring of 2021, Nevan Charles Elam, JD has managed to advance both of small-but-mighty Rezolute Bio's candidates onto the next phases of their journey. This year, on the back of a $130 million investment, Rezolute Bio is prepping its RZ358 candidate, a monoclonal antibody for congenital hyperinsulinism, for a pivotal phase 3 trial. On this week's episode of the Business of Biotech, we're settling in for an interrogation of Elam on the management principles of maintaining multi-candidate clinical momentum among highly disparate candidates and raising big dollars as a small biotech.

7. Digital Pathology And Machine Learning 8/14/2023

   Learn how digital pathology can advance non-clinical pathology workflows and expand opportunities to improve study outcomes with increased speed and flexibility, data quality, and communication pathways.

8. Direct CNS Delivery Of Oligonucleotides: Beware Of The Unexpected 8/14/2023

   As we gain more experience in the CNS ASO administration field, we are beginning to see unexpected scenarios arising despite using “well-understood” oligonucleotide backbones.

9. Best Practices Under ICH E14/S7B For Non-Clinical, Clinical Strategies 8/14/2023

   Scientific experts discuss how the ICH E14/S7B (Q&As) in vitro hERG and in vivo QT assays will be conducted, interpreted, and reported.

10. Solutions For Sustainable Chemistry And Supply Chain 7/31/2023

    Examine how a CRDMO committed to delivering innovative solutions can help meet the unique needs and requirements of clients in the pharmaceutical, biotechnology, and other industries.